肝细胞癌的转化疗法,以改善中期和晚期的治疗策略
Antonio Giorgio1, Massimo De Luca2
1Athena Clinic Center, Via Matese, Piedimonte Matese (CE) 81016, Campania, Italy. agiorgio28@gmail.com.
World journal of clinical cases
|October 7, 2024
概括
管理复杂的肝细胞癌 (HCC) 与门静脉瘤和肝静脉瘤血栓症需要一种多式方法. 对HCC转化疗法的进一步研究对于改善晚期病例的结果至关重要.
科学领域:
- 肝胆道手术 肝胆道手术
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
背景情况:
- 肝细胞癌 (HCC) 存在重大管理挑战,特别是当由门静脉瘤血栓症 (PVTT) 和肝静脉瘤血栓症 (HVTT) 复杂时.
- 由于疾病复杂性,PVTT和HVTT的HCC患者的切除资格是有限的.
- 目前对中期和高级HCC的治疗策略产生令人失望的临床结果.
研究的目的:
- 强调需要采用多模式和多学科方法来管理PVTT和HVTT的HCC.
- 讨论与高级HCC的外科干预相关的复杂性和有争议的结果.
- 强调转化疗法研究对于改善HCC治疗的重要性.
主要方法:
- 基于Song等人的案例报告分析. 在世界临床病例杂志上.
- 复习肝细胞癌转化疗法的挑战.
- 讨论复杂的HCC病例的多模式和多学科治疗策略.
主要成果:
- 一个案例证明了使用PVTT和HVTT管理HCC的复杂性.
- 在先进的HCC病例中,患者的切除资格有限.
- 在复杂HCC的外科干预中报告了有争议的结果.
结论:
- 对于使用PVTT和HVTT管理HCC而言,一种多模式和多学科的方法是必不可少的.
- 转换疗法研究对于推进中级和高级HCC的治疗策略至关重要.
- 对于那些临床结果令人失望的HCC患者,需要改进治疗策略.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:27Tumor Immunotherapy
489
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
489
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K